FDA product code QCM: ß-Galactocerebrosidase (Galc) Newborn Screening Test System

QCM is the FDA product code for ß-galactocerebrosidase (galc) newborn screening test system. It is a Class II device, regulated under 21 CFR 862.1488 and reviewed by the Clinical Chemistry panel. Devices under QCM reach the market by 510(k); FDA lists no cleared 510(k)s for it.

Definition

For quantitative measurement of the activity of ß-galactocerebrosidase (GALC) from newborn dried blood spot specimens as an aid in screening newborns for Krabbe disease.

Classification

FieldValue
Device nameß-Galactocerebrosidase (Galc) Newborn Screening Test System
Device classClass II
Regulation21 CFR 862.1488
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)
Third-party 510(k) review eligibleYes

Recalls for QCM devices

FDA recall records list no recalls for product code QCM.

Frequently asked questions

What is FDA product code QCM?

QCM is the FDA product code for ß-galactocerebrosidase (galc) newborn screening test system. It is a Class II device, regulated under 21 CFR 862.1488 and reviewed by the Clinical Chemistry panel.

What device class is QCM?

Class II, regulation 21 CFR 862.1488. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times